Risk of Thromboembolism With Eltrombopag: A Case Report of Deep Vein Thrombosis and Bilateral Pulmonary Embolism

Eltrombopag is a second-line therapy for refractory thrombocytopenia from immune thrombocytopenic purpura (ITP). The medication is generally well tolerated but can lead to adverse thromboembolic complications in rare instances. We present a case of lower extremity deep vein thrombosis with bilateral...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghumman, Ghulam Mujtaba, Fatima, Huda, Singh, Gunbir, Khalid, Taha, Ayoubi, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911261/
https://www.ncbi.nlm.nih.gov/pubmed/36788875
http://dx.doi.org/10.7759/cureus.33615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911261/
https://www.ncbi.nlm.nih.gov/pubmed/36788875
http://dx.doi.org/10.7759/cureus.33615

Ejemplares similares